Daamen, L. A.
van Goor, I. W. J. M. http://orcid.org/0000-0003-3770-9841
Groot, V. P.
Andel, P. C. M.
Brosens, L. A. A.
Busch, O. R.
Cirkel, G. A.
Mohammad, N. Haj
Heerkens, H. D.
de Hingh, I. H. J. T.
Hoogwater, F.
van Laarhoven, H. W. M.
Los, M.
Meijer, G. J.
de Meijer, V. E.
Pande, R.
Roberts, K. J.
Stoker, J.
Stommel, M. W. J.
van Tienhoven, G.
Verdonk, R. C.
Verkooijen, H. M.
Wessels, F. J.
Wilmink, J. W.
Besselink, M. G.
van Santvoort, H. C.
Intven, M. P. W.
Molenaar, I. Q.
,
Funding for this research was provided by:
Deltaplan Alvleesklierkanker (WOO 21-03)
Article History
Received: 20 March 2024
Accepted: 3 June 2024
First Online: 20 June 2024
Declarations
:
: The RADAR-PANC trial was approved by the Medical Research Ethics Committee Utrecht (MREC; in Dutch METC Utrecht) based on the requirements of the Dutch Medical Research Involving Human Subjects Act (WMO) and other applicable Dutch and European regulations (NL67115.041.20). Written informed consent to participate will be obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.